9:33AM Astex Pharma, Cancer Research Technology and The Institute of Cancer Research announce epigenetic drug discovery collaboration (ASTX) 3.06 -0.01 : "Putting in place this collaboration between the Cancer Research UK-funded drug discovery team at the ICR and Astex provides a powerful route to identify drug candidates for this promising new target. "The deal will ensure that the research programme benefits from the necessary investment to progress the research to its full potential while building on the validation and assay development work that has been carried out at the ICR and funded by Cancer Research UK and others."